SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Linda A. Parker, Micah J. Niphakis, Rachel Downey, Cheryl L. Limebeer, Erin M. Rock, Martin A. Sticht, Heather Morris, Rehab A. Abdullah, Aron H. Lichtman, Benjamin F. Cravatt, Effect of selective inhibition of monoacylglycerol lipase (MAGL) on acute nausea, anticipatory nausea, and vomiting in rats and Suncus murinus, Psychopharmacology, 2015, 232, 3, 583

    CrossRef

  2. 2
    M.A. Sticht, C.L. Limebeer, B.R. Rafla, L.A. Parker, Intra-visceral insular cortex 2-arachidonoylglycerol, but not N-arachidonoylethanolamide, suppresses acute nausea-induced conditioned gaping in rats, Neuroscience, 2015, 286, 338

    CrossRef

  3. 3
    Jayendra Z. Patel, Stephen Ahenkorah, Miia Vaara, Marek Staszewski, Yahaya Adams, Tuomo Laitinen, Dina Navia-Paldanius, Teija Parkkari, Juha R. Savinainen, Krzysztof Walczyński, Jarmo T. Laitinen, Tapio J. Nevalainen, Loratadine analogues as MAGL inhibitors, Bioorganic & Medicinal Chemistry Letters, 2015, 25, 7, 1436

    CrossRef

  4. 4
    Erin M. Rock, Cheryl L. Limebeer, Linda A. Parker, Anticipatory nausea in animal models: a review of potential novel therapeutic treatments, Experimental Brain Research, 2014, 232, 8, 2511

    CrossRef

  5. 5
    Cheryl L. Limebeer, Rehab A. Abdullah, Erin M. Rock, Elizabeth Imhof, Kai Wang, Aron H. Lichtman, Linda A. Parker, Attenuation of anticipatory nausea in a rat model of contextually elicited conditioned gaping by enhancement of the endocannabinoid system, Psychopharmacology, 2014, 231, 3, 603

    CrossRef

  6. 6
    Rebecca A. Kohnz, Daniel K. Nomura, Chemical approaches to therapeutically target the metabolism and signaling of the endocannabinoid 2-AG and eicosanoids, Chem. Soc. Rev., 2014, 43, 19, 6859

    CrossRef

  7. 7
    Linda A. Parker, Conditioned flavor avoidance and conditioned gaping: Rat models of conditioned nausea, European Journal of Pharmacology, 2014, 722, 122

    CrossRef

  8. 8
    Roger G. Pertwee, Elevating endocannabinoid levels: pharmacological strategies and potential therapeutic applications, Proceedings of the Nutrition Society, 2014, 73, 01, 96

    CrossRef

  9. 9
    Keith A. Sharkey, Nissar A. Darmani, Linda A. Parker, Regulation of nausea and vomiting by cannabinoids and the endocannabinoid system, European Journal of Pharmacology, 2014, 722, 134

    CrossRef

  10. 10
    Mahmoud L. Nasr, Xiaomeng Shi, Anna L. Bowman, Michael Johnson, Nikolai Zvonok, David R. Janero, V. Kiran Vemuri, Thomas E. Wales, John R. Engen, Alexandros Makriyannis, Membrane phospholipid bilayer as a determinant of monoacylglycerol lipase kinetic profile and conformational repertoire, Protein Science, 2013, 22, 6
  11. 11
    Pál Pacher, George Kunos, Modulating the endocannabinoid system in human health and disease – successes and failures, FEBS Journal, 2013, 280, 9
  12. 12
    Simona Pisanti, Paola Picardi, Alba D’Alessandro, Chiara Laezza, Maurizio Bifulco, The endocannabinoid signaling system in cancer, Trends in Pharmacological Sciences, 2013, 34, 5, 273

    CrossRef

  13. You have free access to this content13
    DM Kerr, B Harhen, BN Okine, LJ Egan, DP Finn, M Roche, The monoacylglycerol lipase inhibitor JZL184 attenuates LPS-induced increases in cytokine expression in the rat frontal cortex and plasma: differential mechanisms of action, British Journal of Pharmacology, 2013, 169, 4
  14. 14
    Melinda M. Mulvihill, Daniel K. Nomura, Therapeutic potential of monoacylglycerol lipase inhibitors, Life Sciences, 2013, 92, 8-9, 492

    CrossRef

  15. 15
    Bright N Okine, Leonie M Norris, Stephen Woodhams, James Burston, Annie Patel, Stephen PH Alexander, David A Barrett, David A Kendall, Andrew J Bennett, Victoria Chapman, Lack of effect of chronic pre-treatment with the FAAH inhibitor URB597 on inflammatory pain behaviour: evidence for plastic changes in the endocannabinoid system, British Journal of Pharmacology, 2012, 167, 3
  16. 16
    CJ Fowler, Monoacylglycerol lipase – a target for drug development?, British Journal of Pharmacology, 2012, 166, 5
  17. 17
    CL Limebeer, EM Rock, R Mechoulam, LA Parker, The anti-nausea effects of CB1 agonists are mediated by an action at the visceral insular cortex, British Journal of Pharmacology, 2012, 167, 5